Back

blood pressure-lowering and risk of cancer: an individual participant-level data meta-analysis and mendelian randomisation studies

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Challenges in hypertension management Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Milad Nazarzadeh

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Unleashing the potential: early evaluation of blood pressure control with novel measurements in patients with hypertension
Professor Y. Zhang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Adherence to treatment in patients with arterial hypertension at the wartime conditions in Ukrainian population
Professor V. Tseluyko (Kharkiv, UA)
Abstract Slides Video
Presentation thumbnail
Measuring only sitting blood pressure without considering supine blood pressure underestimates cardiovascular risk in the elderly
Professor Y. Zhang (Shanghai, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Challenges in hypertension management

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Short-term effects of blood pressure lowering drugs on cardiovascular events: a systematic review and meta-analysis of randomised, placebo-controlled, doubled-blind trials
thumbnail
Congress Presentation
The association between heart failure diagnosis and the incidence of cancer: a longitudinal analysis of the United Kingdom Biobank
thumbnail
Congress Presentation
Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists and cancer mortality. A real-world registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources